Diabetes Care: Association of Type 2 Diabetes with Structural Brain Abnormalities, Cognitive Performance, and Risk of Dementia

Cognitive dysfunction in type 2 diabetes as an important clinical complications, the risk of type 2 diabetic patients suffering from dementia is 1.

Cognitive dysfunction in type 2 diabetes as an important clinical complications, the risk of type 2 diabetic patients suffering from dementia is 1.

Based on the number of target risk factors, this study explored the associations between patients with type 2 diabetes and dementia, cognitive abilities, and brain abnormalities

Based on the number of target risk factors, this study explored the associations between patients with type 2 diabetes and dementia, cognitive abilities, and brain abnormalities

The results showed that after an average follow-up of 9.

Compared with the control group, patients with type 2 diabetes are estimated to adjust the effect of domain-specific cognitive performance (A) and structural brain abnormalities (B) based on the number of risk factors in the target range

Comparing type 2 diabetes patients with the control group, according to the number of risk factors in the target range, the adjustment effects on domain-specific cognitive performance (A) and structural brain abnormalities (B) are estimated to be compared with the control group , According to the number of risk factors in the target range, the adjustment effect of domain-specific cognitive performance (A) and structural brain abnormality (B) is estimated

In summary, the current research shows that patients with type 2 diabetes who have more risk factors controlled and corrected within the target range have a gradually reduced additional risk of dementia compared with non-diabetic controls

In summary, the current research shows that patients with type 2 diabetes who have more risk factors controlled and corrected within the target range have a gradually reduced additional risk of dementia compared with non-diabetic controls

References: References: April CEvan Gennip ,April CEvan Gennip April CE van Gennip Diabetes CareNov 2021,44(11)2493-2502;DOI:10.
2337/dc21-0149 DOI:10.
2337/dc21-0149 DOI:

here message